Pure Global
Disease/Condition
482 Clinical Trials
10+ Countries

Neoplasms Clinical Trials Database - Free Access to 482 Studies

Access comprehensive clinical trial information for Neoplasms through Pure Global AI's free database. This collection includes 482 clinical trials across multiple phases including Phase 1, N/A, Phase 2. Currently, 54 trials are actively recruiting participants.

Research for Neoplasms is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Boehringer Ingelheim and Bayer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
Phase 1
287
N/A
112
Phase 2
33
Early Phase 1
20
Phase 3
12
By Status
Completed
309
Recruiting
54
Terminated
45
Not yet recruit...
27
Unknown
24
Top Countries
United States of America141
China30
Japan27
France14
Canada10
Top Sponsors
Boehringer Ingelhe...51
Bayer43
Hoffmann-La Roche35
GlaxoSmithKline35
Pfizer19
Recent Trials
Latest clinical trials for Neoplasms
NCT06322693
Phase 1
Recruiting

A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

GlaxoSmithKlineSouth Korea,Spain,United States of America
NCT06346041
Phase 1
Recruiting

Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors

Cancer Institute and Hospital,...China
NCT06289517
Not yet recr...

PET Imaging of 68Ga-Her2-affibody in Tumors With High Her2 Expression

Peking University First Hospit...China
NCT06285929
Enrolling by...

ACS Community Access to Resources Education and Support

American Cancer Society, Inc.United States of America
NCT06256068
Not yet recr...

Determinants of Physical Activity Level in Pediatric Oncological Patients Treated With Cardiotoxic Therapy - a Study Protocol

Medical University of Warsaw
NCT06247865
Not yet recr...

BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE

Portsmouth Hospitals NHS TrustUnited Kingdom
NCT06270628
Not yet recr...

Personalized Live-remote Exercise Training for Cancer Survivors

UMC UtrechtNetherlands
NCT06149312
Not yet recr...

A Prospective, Randomized Trial Assessing the Feasibility of an Advance Care Planning Intervention

Institut de cancérologie Stras...France
NCT06094530
Recruiting

18F-FAPI-RGD PET/CT in Various Tumor Types

Sichuan Provincial People's Ho...China
NCT06077877
Phase 1
Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

GlaxoSmithKlineCanada,United States of America
NCT06048705
Phase 1
Terminated

Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer

GlaxoSmithKlineAustralia,Canada,Germany,Netherlands,Sweden,United States of America
NCT06044441
Not yet recr...

Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)

National Cancer Centre, Singap...Singapore
NCT06058312
Recruiting

Individual Food Preferences for the Mediterranean Diet in Cancer Patients

Centre Antoine LacassagneFrance
NCT06004466
Recruiting

Noninvasive Internal Jugular Venous Oximetry

National Taiwan University Hos...Taiwan
NCT05993299
Phase 2
Recruitment ...

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

GlaxoSmithKlineCanada,Netherlands,United Kingdom,United States of America
jRCT1030230268
Recruiting

Untitled Trial

NCT05980325
Not yet recr...

Exercise For Fighting Oncology Repercussions After Treatment

Universitat Pompeu Fabra
NCT05943990
Phase 1
Terminated

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

GlaxoSmithKlineAustralia,Canada,Germany,Netherlands,Sweden,United States of America
NCT05940259
Recruiting

68Ga-P3 PET/CT Imaging in Prostate

Peking University First Hospit...China
NCT05907551
Not yet recr...

Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions

Institut de cancérologie Stras...France
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Neoplasms Research

Pure Global AI provides free access to 482 clinical trials studying Neoplasms, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Boehringer Ingelheim, Bayer, Hoffmann-La Roche, among others.

Quick Facts
Total Trials482
Countries10+
Sponsors10+
Recruiting54